PanTum Test Plans:
This test is currently available in Delhi-NCR only.
Select your Test Plan
PanTum (With Home Pickup)
11,999 Indian rupeesPanTum (With Home Pickup) Blood Package Advanced( CBC + ESR, CRP, Ferritin + 5 more )
21,999 Indian rupees
₹3000 Special Offer Discount Applied.
₹3000 Special Offer Discount Applied.
₹3000 Special Offer Discount Applied.
₹14999
₹17999
₹24999
​Technology behind PanTum Test
Pantum test is a multi-tumor screening blood test that “filters” asymptomatic healthy individuals by screening for the presence of silently growing benign, premalignant or malignant tumors.
The test has an IVD CE certified sensitivity of 97.5% and a specificity of 99%. It uses EDIM® (Epitope Detection in Monocytes) technology to detect multi-tumor enzyme biomarkers Apo10 and TKTL1 in immune cells (macrophages) which are detectable in all phases of tumor development.
This revolutionary, thoroughly researched and scientifically proven technology leverages our innate immune system thus making it possible to detect tumors in early stages.
The “Cancer-Scan” program combines pre-testing with PanTum® Detect and confirmatory cancer detection diagnostics (advanced imaging techniques and diagnostic pathology) for those who test positive with PanTum® Detect into an integrated multi-tumor screening concept for “timely” detection of tumors.
pplied.
Leveraging the immune system to deliver high accuracy of PanTum test
Consumer Journey Powered by PanTum Test
Don’t wait for onset of symptoms, pre-book your test today
Why PanTum is better for early screening than CTC blood screening tests
Benefits:
-
PanTum® Detect is a simple blood test for indications of almost all types of cancer
-
PanTum® Detect has a high sensitivity of 97.5% (true positives) and specificity of 99% (true negatives) per IVD CE validation study.
-
PanTum® Detect is suitable for preventive health check and offers screened candidates protection from risk of delay in detection of almost all cancers.
-
Only those screened candidates who test positive with PanTum® Detect are exposed to standard protocols for early-stage cancer detection pathology & imaging/endoscopy diagnostics
-
Financial sponsors obtain documented evidence of lower exposure to cancer causing factors to avail adequate “group” health risk financial cover at lower insurance premiums
-
Annual screening increases the chance of detecting a silently growing tumor in early localized stage/s.
Limitations:
-
PanTum® Detect is not suitable for individuals with a compromised immune system which has an effect on circulating macrophage numbers.
-
No screening test provides a result that is 100% accurate or reliable.
-
As per IVD CE validation study:
-
Statistically 1 in 100 candidates screened will receive a false positive result (they don’t have the disease but test positive).
-
Statistically 2.5 in 100 candidates with disease will receive false negative result (they do have disease but test negative).
-
False results are a psychological strain for individuals that get screened with PanTum® Detect.
